Allspring Global Investments Holdings LLC Sells 323,065 Shares of Azenta, Inc. (NASDAQ:AZTA)

Allspring Global Investments Holdings LLC cut its position in shares of Azenta, Inc. (NASDAQ:AZTA - Free Report) by 24.5% in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 994,320 shares of the company's stock after selling 323,065 shares during the quarter. Allspring Global Investments Holdings LLC owned 2.18% of Azenta worth $33,926,000 at the end of the most recent quarter.

A number of other hedge funds also recently bought and sold shares of the company. Farther Finance Advisors LLC boosted its stake in Azenta by 788.1% in the 1st quarter. Farther Finance Advisors LLC now owns 968 shares of the company's stock worth $33,000 after purchasing an additional 859 shares during the period. Picton Mahoney Asset Management grew its holdings in shares of Azenta by 305.7% during the fourth quarter. Picton Mahoney Asset Management now owns 706 shares of the company's stock valued at $35,000 after buying an additional 532 shares in the last quarter. Headlands Technologies LLC acquired a new position in Azenta during the fourth quarter valued at $40,000. Covestor Ltd lifted its stake in Azenta by 64.2% in the 4th quarter. Covestor Ltd now owns 2,043 shares of the company's stock worth $102,000 after acquiring an additional 799 shares in the last quarter. Finally, Quarry LP acquired a new stake in Azenta during the 4th quarter worth about $110,000. 99.08% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Separately, Needham & Company LLC reduced their price target on shares of Azenta from $59.00 to $40.00 and set a "buy" rating for the company in a research report on Wednesday, May 7th.

Azenta Trading Up 3.4%

NASDAQ AZTA traded up $1.09 on Wednesday, reaching $32.85. The stock had a trading volume of 805,832 shares, compared to its average volume of 733,045. Azenta, Inc. has a 1 year low of $23.91 and a 1 year high of $63.58. The business has a 50 day moving average price of $28.21 and a 200 day moving average price of $37.99. The company has a market capitalization of $1.50 billion, a price-to-earnings ratio of 67.57 and a beta of 1.64.

Azenta (NASDAQ:AZTA - Get Free Report) last announced its quarterly earnings results on Wednesday, May 7th. The company reported $0.05 EPS for the quarter, missing the consensus estimate of $0.09 by ($0.04). Azenta had a negative net margin of 10.31% and a positive return on equity of 1.30%. During the same period in the prior year, the firm posted $0.06 earnings per share. The business's revenue was up 5.1% on a year-over-year basis. On average, analysts anticipate that Azenta, Inc. will post 0.53 earnings per share for the current fiscal year.

Azenta Profile

Azenta, Inc provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services.